Candel Therapeutics, Inc.

Candel Therapeutics, Inc. financial statements

Candel Therapeutics, Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

FY2025

RevenueUSD 0EODHD
Net income−USD 38.18M10-K
Cash and equivalentsUSD 119.73M10-Q
Total debtUSD 010-K

Candel Therapeutics, Inc. financials on 6ix · Candel Therapeutics, Inc. on 6ix